A.M. (Amalia M.) Dolga, Prof Dr

Education and Research experience:
2020 - current Associate Professor
2015- 2019 Assistant Professor
Rosalind Franklin Fellow
Groningen Research Institute of Pharmacy - GRIP, Department of Molecular Pharmacology
University of Groningen, Groningen, The Netherlands.
Lab theme: Defining the molecular mechanisms of mitochondrial dysfunction and inflammation in neurodegeneration
2015 Privatdozent
Philipps-Universität Marburg,
Faculty of Pharmacy, Marburg, Germany
2013- 2015 Habilitation
Institute of Pharmacology and Clinical Pharmacy, Philipps-Universität Marburg, Marburg, Germany
Topic: The role of SK channels in neuronal degeneration and inflammation
2008-2015 Postdoctoral Fellow
Institute of Pharmacology and Clinical Pharmacy, Philipps-Universität Marburg, Marburg, Germany
Advisor: Carsten Culmsee, Ph.D.
Topic 1): Defining the molecular signaling pathways by which mitochondrial dysfunction leads to neuronal cell death.
Topic 2): Defining how modulation of small conductance calcium-activated potassium channels promotes neuronal survival in neurodegenerative conditions.
2004- 2008 Graduate Student
University of Groningen, Groningen, The Netherlands
Advisor: Ulrich Eisel, Ph.D.
Topic: Defining how inflammation contribute to neuronal survival and which molecular pathways affect these processes.
2001- 2003 M.Sc.
Master research in “Chemistry of biological active compounds”, Department of Chemistry, West University of Timisoara, Romania
Master thesis: University of Bremen, Department of Biochemistry and Molecular Biology, Germany.
1997- 2001 B.Sc.
Chemistry and Biology, The West University of Timisoara, Romania.
Grant Support and Awards:
2022-2023 ParkinsonFonds, Research Grant ( € 250.000)
PI: Amalia Dolga
Title: The neuro-immune interaction in Parkinson's disease.
2020-2021 Alzheimer Nederland, Research Grant ( € 100.000)
PI: Amalia Dolga
Title: Targeting SK channels in Alzheimer's disease.
2019-2021 ParkinsonFonds, Research Grant ( € 250.000)
PI: Amalia Dolga
Title: The function of LRRK2 in the immune cells of Parkinson's disease.
2015-present Rosalind Franklin Fellowship
Lab theme: Defining the molecular mechanisms of mitochondrial dysfunction and inflammation in neurodegeneration
2014-2017 Deutsche Forschungsgemeinschaft (DFG), Research Grant
PI: Amalia Dolga
Title: The function of potassium SK channels in neuronal mitochondria.
A total of € 211.000 to cover salary for a Ph.D. position (BAT IIa/2), plus consumables for 3 years
2014-2015 Forschungsförderfonds (Research Grant), Philipps University Marburg, (€ 40.000)
Co-PI: Amalia Dolga & Braxton Norwood, Titel: Es werde Licht: Optogenetic tools for epilepsy
2013-2015 Co-writer of funded European 7th Framework Programme
PI: David Henshall, Title: MicroRNA in the pathogenesis, treatment and prevention of epilepsy.
A total of € 124 200 to cover salary for 2 years for a Post-doc position (BAT IIa).
2013 Travel award based on scientific merit, Seahorse Bioscience for the oral presentation on ”SK channel activation preserves mitochondrial function and supports neuronal survival under conditions of ER stress and oxidative damage”, 4th ECS Workshop “Ca2+ and cell death” Leuven, Belgium
2012 Conference fellowship by the Royal College of Surgeons in Ireland, for research on “Novel mitochondrial KCNN2/KCa2.2 channels mediate neuroprotective effects” presented at the Neurons Under Stress Meeting, Royal College of Surgeons in Ireland, Dublin, Ireland.
2010 European Calcium Society, Travel award based on scientific merit for research on “Activation of small conductance KCa2 channels prevents neuronal death induced by delayed calcium deregulation” presented at the European Calcium Society Meeting, Warsaw, Poland.
2009 Deutsche Gesellschaft für Neurologie, Travel award based on scientific merit for the research paper “Activation of small conductance KCa2 channels attenuates [Ca2+]i increases and provides neuroprotection against glutamate-induced neurotoxicity” presented at the Society for Neuroscience annual meeting, Chicago, USA.
2009 Poster prize, Annual conference of the German pharmaceutical society (DPhG) for the research paper “Activation of small conductance KCa2 channels provides neuroprotection against glutamate toxicity in vitro and cerebral ischemia in vivo”, Jena, Germany
2009 JAD Press release, “Statins Can Protect Against Alzheimer’s Disease, According to New Study”
2008 Science-Daily Press release, “Lovastatin Shown To Slow Progression Of Alzheimer's Disease”, http://www.sciencedaily.com/releases/2008/04/080409114625.htm
2008 Internationale Stichting Alzheimer Onderzoek (ISAO)Grant for printing the PhD dissertation entitled “Neuroprotective signaling mechanisms in the mammalian brain”, Rijksuniversiteit Groningen, The Netherlands.
2002 – 2003 European region action scheme for the mobility of university students at University of Bremen, Department of Biochemistry and Molecular Biology, Germany.
2001 Conference Grant sponsored by NATO – Advanced Study Institute (ASI) for the study on “Aspects of tautomeric transitions driven by proton tunneling” presented at the “Metal-ligand interactions in molecular, nano, micro- and macro-systems in complex environments” conference held in Cetraro, Italy.
1997 – 2001 Governmental scholarship for excellent performance.
Last modified: | 25 June 2022 3.34 p.m. |